ADSL and neoplasm: Taken together, these indirect lines of evidence support the notion that microbe-derived AMPs may reduce tumor burden in vivo through direct cytotoxicity while simultaneously shaping the TME by modulating immune-cell function and remodeling the cytokine milieu.